Novel Quinazoline-Based Compounds Impair Prostate Tumorigenesis by Targeting Tumor Vascularity
Jason B. Garrison(University of Kentucky), Natasha Kyprianou(Tisch Hospital)
Cited by 52
Related Papers
Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer
|The Prostate|2006|87
Doxazosin Induces Apoptosis of Benign and Malignant Prostate Cells via a Death Receptor–Mediated Pathway
|Cancer Research|2006|85
PARP-1 regulates epithelial-mesenchymal transition (EMT) in prostate tumorigenesis
|Carcinogenesis|2014|67